BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 12775885)

  • 1. Association of methylenetetrahydrofolate reductase gene polymorphism with carotid atherosclerosis depending on smoking status in a Japanese general population.
    Inamoto N; Katsuya T; Kokubo Y; Mannami T; Asai T; Baba S; Ogata J; Tomoike H; Ogihara T
    Stroke; 2003 Jul; 34(7):1628-33. PubMed ID: 12775885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An association of 5,10-methylenetetrahydrofolate reductase (MTHFR) gene polymorphism and common carotid atherosclerosis.
    Kawamoto R; Kohara K; Tabara Y; Miki T; Doi T; Tokunaga H; Konishi I
    J Hum Genet; 2001; 46(9):506-10. PubMed ID: 11558898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphism in methylenetetrahydrofolate reductase gene: its impact on plasma homocysteine levels and carotid atherosclerosis in ESRD patients receiving hemodialysis.
    Lim PS; Hung WR; Wei YH
    Nephron; 2001 Mar; 87(3):249-56. PubMed ID: 11287760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS).
    McQuillan BM; Beilby JP; Nidorf M; Thompson PL; Hung J
    Circulation; 1999 May; 99(18):2383-8. PubMed ID: 10318658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low potentiality of angiotensin-converting enzyme gene insertion/deletion polymorphism as a useful predictive marker for carotid atherogenesis in a large general population of a Japanese city: the Suita study.
    Mannami T; Katsuya T; Baba S; Inamoto N; Ishikawa K; Higaki J; Ogihara T; Ogata J
    Stroke; 2001 Jun; 32(6):1250-6. PubMed ID: 11387483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperhomocysteinemia, diabetes mellitus, and carotid atherosclerosis independently increase atherosclerotic vascular disease outcome in Japanese patients with end-stage renal disease.
    Haraki T; Takegoshi T; Kitoh C; Kajinami K; Wakasugi T; Hirai J; Shimada T; Kawashiri M; Inazu A; Koizumi J; Mabuchi H
    Clin Nephrol; 2001 Aug; 56(2):132-9. PubMed ID: 11522090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of methylenetetrahydrofolate reductase (MTHFR) variant C677T and risk of carotid atherosclerosis: a cross-sectional analysis of 730 Chinese Han adults in Chongqing.
    Peng X; Zhou Y; Wu X; Wang X; Bai H; Li Y; Wang Z; Chen X; Wang Y
    BMC Cardiovasc Disord; 2020 May; 20(1):222. PubMed ID: 32404177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of methylenetetrahydrofolate reductase C677T polymorphism with markers of subclinical atherosclerosis: the Cardiovascular Risk in Young Finns Study.
    Collings A; Raitakari OT; Juonala M; Rontu R; Kähönen M; Hutri-Kähönen N; Rönnemaa T; Marniemi J; Viikari JS; Lehtimäki T
    Scand J Clin Lab Invest; 2008; 68(1):22-30. PubMed ID: 17934972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MTHFR gene polymorphism as a risk factor for silent brain infarcts and white matter lesions in the Japanese general population: The NILS-LSA Study.
    Kohara K; Fujisawa M; Ando F; Tabara Y; Niino N; Miki T; Shimokata H;
    Stroke; 2003 May; 34(5):1130-5. PubMed ID: 12690212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum homocysteine, MTHFR gene polymorphism, and carotid intimal-medial thickness in NIDDM subjects.
    Mazza A; Motti C; Nulli A; Pastore A; Andreotti F; Ammaturo V; Bianco P; Santoro E; Federici G; Cortese C
    J Thromb Thrombolysis; 1999 Oct; 8(3):207-12. PubMed ID: 10500310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of carotid stiffening associated with MTHFR 677TT genotype in cardiorespiratory fit adults.
    Iemitsu M; Murakami H; Sanada K; Yamamoto K; Kawano H; Gando Y; Miyachi M
    Physiol Genomics; 2010 Jul; 42(2):259-65. PubMed ID: 20406848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylenetetrahydrofolate reductase gene C677T polymorphism, homocysteine, vitamin B12, and DNA damage in coronary artery disease.
    Andreassi MG; Botto N; Cocci F; Battaglia D; Antonioli E; Masetti S; Manfredi S; Colombo MG; Biagini A; Clerico A
    Hum Genet; 2003 Feb; 112(2):171-7. PubMed ID: 12522558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of association between carotid intima-media thickness and methylenetetrahydrofolate reductase gene polymorphism or serum homocysteine in non-insulin-dependent diabetes mellitus.
    Mazza A; Motti C; Nulli A; Marra G; Gnasso A; Pastore A; Federici G; Cortese C
    Metabolism; 2000 Jun; 49(6):718-23. PubMed ID: 10877195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5,10-Methylenetetrahydrofolate reductase polymorphism and early organ damage in primary hypertension.
    Ravera M; Viazzi F; Berruti V; Leoncini G; Zagami P; Bezante GP; Rosatto N; Ravazzolo R; Pontremoli R; Deferrari G
    Am J Hypertens; 2001 Apr; 14(4 Pt 1):371-6. PubMed ID: 11336184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the C677T Polymorphism of the 5, 10-Methylenetetrahydrofolate Reductase (MTHFR) Gene in Patients with Carotid Artery Atherosclerosis.
    Li A; Huang W; Yang Q; Peng L; Liu Q
    Med Sci Monit; 2020 Jul; 26():e920320. PubMed ID: 32675800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoter polymorphism in the endotoxin receptor (CD14) is associated with increased carotid atherosclerosis only in smokers: the Carotid Atherosclerosis Progression Study (CAPS).
    Risley P; Jerrard-Dunne P; Sitzer M; Buehler A; von Kegler S; Markus HS;
    Stroke; 2003 Mar; 34(3):600-4. PubMed ID: 12624278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of MTHFR 677C>T on plasma total homocysteine levels in renal graft recipients.
    Födinger M; Wölfl G; Fischer G; Rasoul-Rockenschaub S; Schmid R; Hörl WH; Sunder-Plassmann G
    Kidney Int; 1999 Mar; 55(3):1072-80. PubMed ID: 10027946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential of carotid enlargement as a useful indicator affected by high blood pressure in a large general population of a Japanese city: the Suita study.
    Mannami T; Baba S; Ogata J
    Stroke; 2000 Dec; 31(12):2958-65. PubMed ID: 11108756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The C677T methylenetetrahydrofolate reductase polymorphism influences the homocysteine-lowering effect of hormone replacement therapy.
    Brown CA; McKinney KQ; Young KB; Norton HJ
    Mol Genet Metab; 1999 May; 67(1):43-8. PubMed ID: 10329022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The A677V methylenetetrahydrofolate reductase gene polymorphism and carotid atherosclerosis.
    Bova I; Chapman J; Sylantiev C; Korczyn AD; Bornstein NM
    Stroke; 1999 Oct; 30(10):2180-2. PubMed ID: 10512925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.